Eveline Verheijen is leading our operations department and overseeing the project management and clinical monitoring staff. Eveline has over 12 years’ experience in clinical oncology study conduct. After receiving her Master’s degree in Biomedical Sciences from the VU University, Amsterdam she started her career in 2005 at Bayer as a Clinical Research Associate (CRA). After two years she moved to GlaxoSmithKline as a senior CRA, where she was predominantly involved in oncology and hematology studies (mostly breast cancer, leukemia, and non-Hodgkin lymphoma). She gained extensive experience in both early phase and phase III studies. Eveline joined SMS-oncology in September 2011 as a Project Manager/ Start-up Specialist and managed many international Phase I-IV trials involving a variety of indications and drug modalities. In February 2015 she took the position of Project Director where she was responsible for project management and leadership on the planning, preparation and execution of clinical projects as well as line management activities. With her drive to improve operational processes at both project and organizational levels, Eveline got promoted to Director Operations in January 2017 and to Chief Operating Officer in January 2019. She currently heads the Clinical Operations department and is accountable for management of all operational activities, and to develop and implement the operational strategy and excellence performance in collaboration with the management team.